May 20, 2025

A View of the Cellview

Exploring the features and benefits of a new retinal imaging system

The Ophthalmologist

May 15, 2025

Cases of Sterile IOI Following High-Dose Aflibercept

The incidence of IOI following 8 mg aflibercept may be higher than previously observed in clinical trials.

Conexiant

May 15, 2025

Visual Difficulty, Falls, and Mortality

Recurrent falls were associated with a nearly 50% increased hazard of mortality.

Conexiant

May 12, 2025

Why Address Gender and Racial Disparities in Ophthalmic Surgical Volume?

Researchers note the “burgeoning need” of a shrinking workforce combined with an aging population

Conexiant

May 09, 2025

OcuSciences Gets U.S. Food and Drug Administration Clearance for Retina Health Assessment Device

OcuSciences, Inc. has developed an innovative device, the OcuMet Beacon, uniquely designed for infrared and autofluorescence retinal imaging, with FDA clearance. Learn more at www.ocusciences.com. Source: Optometric Management

Optometric Management

May 08, 2025

Alkeus Presents Data at ARVO on Oral Gildeuretinol for GA

Data were presented from Alkeus Pharmaceuticals’ phase 2 SAGA clinical study in GA secondary to AMD.

Ophthalmology Management

May 05, 2025

FDA Clears OcuMet Beacon for Retinal Health Imaging

OcuSciences, Inc. announced at ARVO that the FDA has granted marketing clearance for its flagship device, the OcuMet Beacon, a confocal scanning ophthalmoscope designed for infrared and autofluorescence imaging of the retina.

Retinal Physician

May 05, 2025

PDS Updates Continue to Reduce Treatment Burden for Patients with nAMD, DME, and DR

These types of improvements are relatively common after initial approval and are the result of optimization as surgical techniques and knowledge evolve.

Conexiant

May 01, 2025

Migaldendranib May Move the Needle in AMD, DME

Michael A. Singer, MD, shares early phase 2 data supporting D-4517.2 as a safe and effective subcutaneous therapy, reducing injection burden and preserving vision.

Retinal Physician